Clinical trials
Hematologic Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 9 |
| 2022 | 8 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Active, not recruiting | 14 |
| Recruiting | 6 |
| Terminated | 4 |
| Enrolling by invitation | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Seagen Inc. | 6 |
| Loxo Oncology, Inc. | 4 |
| Vertex Pharmaceuticals Incorporated | 4 |
| Pfizer | 3 |
| Sierra Oncology LLC - a GSK company | 3 |
| Agios Pharmaceuticals, Inc. | 2 |
| Boston Children's Hospital | 2 |
| Canadian Myeloma Research Group | 2 |
| Cogent Biosciences, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 68 |
| Anemia | 13 |
| Bone Marrow Diseases | 12 |
| Genetic Diseases, Inborn | 12 |
| Myeloproliferative Disorders | 12 |
| Neoplasms | 12 |
| Anemia, Sickle Cell | 9 |
| Blood Coagulation Disorders | 9 |
| Hemoglobinopathies | 9 |
| Hemorrhagic Disorders | 9 |
Trials
Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.